IL-13 Targeting Biologics for the Treatment of Atopic Dermatitis - Episode 6
Guidance for Moving to Advanced Systemic Therapy and Biologic Agents
Published on:
Panelists discuss recent guideline changes regarding advanced systemic therapy in atopic dermatitis (AD), focusing on when to transition a patient to systemic agents and when biologics should be considered for the treatment of moderate to severe AD.
Video content above is prompted by the following:
- Discuss changes in patients’ quality of life with atopic dermatitis treatments.
- Recent changes in guidelines and moving to advanced systemic therapy in AD.
- When would you transition a patient to systemic agents? When should biologics be considered for treatment of moderate to severe AD?
